{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:39:11Z","timestamp":1793277551338,"version":"4.5.0"},"reference-count":65,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,3,29]]},"DOI":"10.1167\/iovs.18-24254","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T11:36:50Z","timestamp":1553859410000},"page":"1204","source":"Crossref","is-referenced-by-count":38,"title":["The Utah Protocol for Postmortem Eye Phenotyping and Molecular Biochemical Analysis"],"prefix":"10.1167","volume":"60","author":[{"given":"Leah A.","family":"Owen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Utah, School of Medicine, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Shakoor","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Utah, School of Medicine, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise J.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Utah, School of Medicine, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre A.","family":"Hejazi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Utah, School of Medicine, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Wade","family":"McEntire","sequence":"additional","affiliation":[{"name":"Utah Lions Eye Bank, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Utah Lions Eye Bank, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Farrer","sequence":"additional","affiliation":[{"name":"Departments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Kim","sequence":"additional","affiliation":[{"name":"Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Vitale","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Utah, School of Medicine, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"DeAngelis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Utah, School of Medicine, Salt Lake City, Utah, United States"},{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, United States"},{"name":"Department of Population Health Sciences, University of Utah, School of Medicine, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-4-1204-b01","doi-asserted-by":"crossref","unstructured":"DeAngelis MM, Lane AM, Shah CP, Ott J, Dryja TP, Miller JW. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 2004; 122: 575\u2013580.","DOI":"10.1001\/archopht.122.4.575"},{"key":"i1552-5783-60-4-1204-b02","doi-asserted-by":"crossref","unstructured":"Deangelis MM, Ji F, Adams S, et al. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology. 2008; 115: 1209\u20131215.e7.","DOI":"10.1016\/j.ophtha.2007.10.032"},{"key":"i1552-5783-60-4-1204-b03","doi-asserted-by":"crossref","unstructured":"Owen LA, Morrison MA, Ahn J, et al. FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Invest Ophthalmol Vis Sci. 2014; 55: 3543\u20133554.","DOI":"10.1167\/iovs.14-14047"},{"key":"i1552-5783-60-4-1204-b04","doi-asserted-by":"crossref","unstructured":"Yonekawa Y, Miller JW, Kim IK. Age-related macular degeneration: advances in management and diagnosis. J Clin Med. 2015; 4: 343\u2013359.","DOI":"10.3390\/jcm4020343"},{"key":"i1552-5783-60-4-1204-b05","doi-asserted-by":"crossref","unstructured":"Lei J, Balasubramanian S, Abdelfattah NS, Nittala MG, Sadda SR. Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017; 255: 1551\u20131558.","DOI":"10.1007\/s00417-017-3693-y"},{"key":"i1552-5783-60-4-1204-b06","doi-asserted-by":"crossref","unstructured":"Garrity ST, Sarraf D, Freund KB, Sadda SR. Multimodal imaging of nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2018; 59: AMD48\u2013AMD64.","DOI":"10.1167\/iovs.18-24158"},{"key":"i1552-5783-60-4-1204-b07","doi-asserted-by":"crossref","unstructured":"DeAngelis MM, Owen LA, Morrison MA, et al. Genetics of age-related macular degeneration (AMD). Hum Mol Genet. 2017; 26: R45\u2013R50.","DOI":"10.1093\/hmg\/ddx228"},{"key":"i1552-5783-60-4-1204-b08","doi-asserted-by":"crossref","unstructured":"Morgan DJ, DeAngelis MM. Differential gene expression in age-related macular degeneration. Cold Spring Harb Perspect Med. 2015; 5: a017210","DOI":"10.1101\/cshperspect.a017210"},{"key":"i1552-5783-60-4-1204-b09","doi-asserted-by":"crossref","unstructured":"Fan Q, Maranville JC, Fritsche L, et al. HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization. Int J Epidemiol. 2017; 46: 1891\u20131902.","DOI":"10.1093\/ije\/dyx189"},{"key":"i1552-5783-60-4-1204-b10","doi-asserted-by":"crossref","unstructured":"Lee V, Rekhi E, Hoh Kam J, Jeffery G. Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging. 2012; 33: 2382\u20132389.","DOI":"10.1016\/j.neurobiolaging.2011.12.002"},{"key":"i1552-5783-60-4-1204-b11","doi-asserted-by":"crossref","unstructured":"Morrison MA, Silveira AC, Huynh N, et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011; 5: 538\u2013568.","DOI":"10.1186\/1479-7364-5-6-538"},{"key":"i1552-5783-60-4-1204-b12","doi-asserted-by":"crossref","unstructured":"Millen AE, Meyers KJ, Liu Z, et al. Association between vitamin D status and age-related macular degeneration by genetic risk. JAMA Ophthalmol. 2015; 133: 1171\u20131179.","DOI":"10.1001\/jamaophthalmol.2015.2715"},{"key":"i1552-5783-60-4-1204-b13","doi-asserted-by":"crossref","unstructured":"Kim KL, Park SP. Association between serum vitamin D deficiency and age-related macular degeneration in Koreans: clinical case-control pilot study. Medicine (Baltimore). 2018; 97: e11908.","DOI":"10.1097\/MD.0000000000011908"},{"key":"i1552-5783-60-4-1204-b14","doi-asserted-by":"crossref","unstructured":"Hermann MM, van Asten F, Muether PS, et al. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration. Ophthalmology. 2014; 121: 905\u2013910.","DOI":"10.1016\/j.ophtha.2013.10.047"},{"key":"i1552-5783-60-4-1204-b15","doi-asserted-by":"crossref","unstructured":"Burgess S, Davey Smith G. Mendelian randomization implicates high-density lipoprotein cholesterol-associated mechanisms in etiology of age-related macular degeneration. Ophthalmology. 2017; 124: 1165\u20131174.","DOI":"10.1016\/j.ophtha.2017.03.042"},{"key":"i1552-5783-60-4-1204-b16","doi-asserted-by":"crossref","unstructured":"Yan Q, Ding Y, Liu Y, et al. Genome-wide analysis of disease progression in age-related macular degeneration. Hum Mol Genet. 2018; 27: 929\u2013940.","DOI":"10.1093\/hmg\/ddy002"},{"key":"i1552-5783-60-4-1204-b17","doi-asserted-by":"crossref","unstructured":"Forest DL, Johnson LV, Clegg DO. Cellular models and therapies for age-related macular degeneration. Dis Model Mech. 2015; 8: 421\u2013427.","DOI":"10.1242\/dmm.017236"},{"key":"i1552-5783-60-4-1204-b18","doi-asserted-by":"crossref","unstructured":"Maguire MG, Martin DF, Ying GS, et al.; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016; 123: 1751\u20131761.","DOI":"10.1016\/j.ophtha.2016.03.045"},{"key":"i1552-5783-60-4-1204-b19","doi-asserted-by":"crossref","unstructured":"Maguire MG, Ying G-S, Jaffe GJ, et al. Single-nucleotide polymorphisms associated with age-related macular degeneration and lesion phenotypes in the comparison of age-related macular degeneration treatments trials. JAMA Ophthalmol. 2016; 134: 674\u2013681.","DOI":"10.1001\/jamaophthalmol.2016.0669"},{"key":"i1552-5783-60-4-1204-b20","doi-asserted-by":"crossref","unstructured":"Miller JW. Beyond VEGF \u2013 The Weisenfeld Lecture. Invest Ophthalmol Vis Sci. 2016; 57: 6911\u20136918.","DOI":"10.1167\/iovs.16-21201"},{"key":"i1552-5783-60-4-1204-b21","doi-asserted-by":"crossref","unstructured":"Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y. Pharmacogenetics of complement factor H Y402H polymorphism and treatment of neovascular AMD with anti-VEGF agents: a meta-analysis. Sci Rep. 2015; 5: 14517.","DOI":"10.1038\/srep14517"},{"key":"i1552-5783-60-4-1204-b22","doi-asserted-by":"crossref","unstructured":"Volz C, Pauly D. Antibody therapies and their challenges in the treatment of age-related macular degeneration. Eur J Pharm Biopharm. 2015; 95: 158\u2013172.","DOI":"10.1016\/j.ejpb.2015.02.020"},{"key":"i1552-5783-60-4-1204-b23","doi-asserted-by":"crossref","unstructured":"Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology. 2014; 121: 693\u2013701.","DOI":"10.1016\/j.ophtha.2013.09.044"},{"key":"i1552-5783-60-4-1204-b24","doi-asserted-by":"crossref","unstructured":"Stamer WD, Williams AM, Pflugfelder S, Coupland SE. Accessibility to and quality of human eye tissue for research: a cross-sectional survey of ARVO members. Invest Ophthalmol Vis Sci. 2018; 59: 4783\u20134792.","DOI":"10.1167\/iovs.18-25319"},{"key":"i1552-5783-60-4-1204-b25","doi-asserted-by":"crossref","unstructured":"Curcio CA. Imaging maculopathy in post-mortem human eyes. Vision Res. 2005; 45: 3496\u20133503.","DOI":"10.1016\/j.visres.2005.07.038"},{"key":"i1552-5783-60-4-1204-b26","doi-asserted-by":"crossref","unstructured":"Olsen TW, Liao A, Robinson HS, Palejwala NV, Sprehe N. The nine-step Minnesota grading system for eyebank eyes with age related macular degeneration: a systematic approach to study disease stages. Invest Ophthalmol Vis Sci. 2017; 58: 5497\u20135506.","DOI":"10.1167\/iovs.17-22161"},{"key":"i1552-5783-60-4-1204-b27","doi-asserted-by":"crossref","unstructured":"Seddon JM, McLeod DS, Bhutto IA, et al. Histopathological insights into choroidal vascular loss in clinically documented cases of age-related macular degeneration. JAMA Ophthalmol. 2016; 134: 1272\u20131280.","DOI":"10.1001\/jamaophthalmol.2016.3519"},{"key":"i1552-5783-60-4-1204-b28","doi-asserted-by":"crossref","unstructured":"Ezzat M-K, Hann CR, Vuk-Pavlovic S, Pulido JS. Immune cells in the human choroid. Br J Ophthalmol. 2008; 92: 976\u2013980.","DOI":"10.1136\/bjo.2007.129742"},{"key":"i1552-5783-60-4-1204-b29","doi-asserted-by":"crossref","unstructured":"Zanzottera EC, Messinger JD, Ach T, Smith RT, Freund KB, Curcio CA. The Project MACULA retinal pigment epithelium grading system for histology and optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015; 56: 3253\u20133268.","DOI":"10.1167\/iovs.15-16431"},{"key":"i1552-5783-60-4-1204-b30","doi-asserted-by":"crossref","unstructured":"Kim EJ, Grant GR, Bowman AS, Haider N, Gudiseva HV, Chavali VRM. Complete transcriptome profiling of normal and age-related macular degeneration eye tissues reveals dysregulation of anti-sense transcription. Sci Rep. 2018; 8: 3040.","DOI":"10.1038\/s41598-018-21104-7"},{"key":"i1552-5783-60-4-1204-b31","doi-asserted-by":"crossref","unstructured":"Newman AM, Gallo NB, Hancox LS, et al. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 2012; 4: 16.","DOI":"10.1186\/gm315"},{"key":"i1552-5783-60-4-1204-b32","doi-asserted-by":"crossref","unstructured":"Ghazi NG, Dibernardo C, Ying H, Mori K, Gehlbach PL. Optical coherence tomography of peripheral retinal lesions in enucleated human eye specimens with histologic correlation. Am J Ophthalmol. 2006; 141: 740\u2013742.","DOI":"10.1016\/j.ajo.2005.10.058"},{"key":"i1552-5783-60-4-1204-b33","doi-asserted-by":"crossref","unstructured":"Brown NH, Koreishi AF, McCall M, Izatt JA, Rickman CB, Toth CA. Developing SDOCT to assess donor human eyes prior to tissue sectioning for research. Graefes Arch Clin Exp Ophthalmol. 2009; 247: 1069\u20131080.","DOI":"10.1007\/s00417-009-1044-3"},{"key":"i1552-5783-60-4-1204-b34","doi-asserted-by":"crossref","unstructured":"Bagheri N, Bell BA, Bonilha VL, Hollyfield JG. Imaging human postmortem eyes with SLO and OCT. Adv Exp Med Biol. 2012; 723: 479\u2013488.","DOI":"10.1007\/978-1-4614-0631-0_60"},{"key":"i1552-5783-60-4-1204-b35","unstructured":"Curcio CA, Zanzottera EC, Ach T, Balaratnasingam C, Freund KB. Activated retinal pigment epithelium, an optical coherence tomography biomarker for progression in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2017; 58: BIO211\u2013BIO226."},{"key":"i1552-5783-60-4-1204-b36","unstructured":"Kim B-J, Sprehe N, Morganti A, Wordinger RJ, Clark AF. The effect of postmortem time on the RNA quality of human ocular tissues. Mol Vis. 2013; 19: 1290\u20131295."},{"key":"i1552-5783-60-4-1204-b37","unstructured":"Curcio CA, Medeiros NE, Millican CL. The Alabama age-related macular degeneration grading system for donor eyes. Invest Ophthalmol Vis Sci. 1998; 39: 1085\u20131096."},{"key":"i1552-5783-60-4-1204-b38","doi-asserted-by":"crossref","unstructured":"Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991; 98: 1128\u20131134.","DOI":"10.1016\/S0161-6420(91)32186-9"},{"key":"i1552-5783-60-4-1204-b39","unstructured":"Davis MD, Gangnon RE, Lee L-Y, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005; 123: 1484\u20131498."},{"key":"i1552-5783-60-4-1204-b40","doi-asserted-by":"crossref","unstructured":"Malik KJ, Chen C-D, Olsen TW. Stability of RNA from the retina and retinal pigment epithelium in a porcine model simulating human eye bank conditions. Invest Ophthalmol Vis Sci. 2003; 44: 2730\u20132735.","DOI":"10.1167\/iovs.02-1120"},{"key":"i1552-5783-60-4-1204-b41","doi-asserted-by":"crossref","unstructured":"Beach TG, Sue LI, Walker DG, et al. The Sun Health Research Institute brain donation program: description and experience, 1987\u20132007. Cell Tissue Bank. 2008; 9: 229\u2013245.","DOI":"10.1007\/s10561-008-9067-2"},{"key":"i1552-5783-60-4-1204-b42","doi-asserted-by":"crossref","unstructured":"Trabzuni D, Ryten M, Walker R, et al. Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem. 2011; 119: 275\u2013282.","DOI":"10.1111\/j.1471-4159.2011.07432.x"},{"key":"i1552-5783-60-4-1204-b43","doi-asserted-by":"crossref","unstructured":"Sj\u00f6holm LK, Ransome Y, Ekstr\u00f6m TJ, Karlsson O. Evaluation of post-mortem effects on global brain DNA methylation and hydroxymethylation. Basic Clin Pharmacol Toxicol. 2018; 122: 208\u2013213.","DOI":"10.1111\/bcpt.12875"},{"key":"i1552-5783-60-4-1204-b44","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001; 132: 668\u2013681.","DOI":"10.1016\/S0002-9394(01)01218-1"},{"key":"i1552-5783-60-4-1204-b45","doi-asserted-by":"crossref","unstructured":"Bowes Rickman C, Ebright JN, Zavodni ZJ, et al . Defining the human macula transcriptome and candidate retinal disease genes using EyeSAGE. Invest Ophthalmol Vis Sci. 2006; 47: 2305\u20132316.","DOI":"10.1167\/iovs.05-1437"},{"key":"i1552-5783-60-4-1204-b46","unstructured":"Pennington KL, DeAngelis MM. Epigenetic mechanisms of the aging human retina. J Exp Neurosci. 2016; 9: 51\u201379."},{"key":"i1552-5783-60-4-1204-b47","doi-asserted-by":"crossref","unstructured":"Liang Q, Dharmat R, Owen L, et al. Single-nuclei RNA-seq on human retinal tissue provides improved transcriptome profiling. bioRxiv. 2018: 468207.","DOI":"10.1101\/468207"},{"key":"i1552-5783-60-4-1204-b48","doi-asserted-by":"crossref","unstructured":"Fritsche LG, Igl W, Bailey JNC, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016; 48: 134\u2013143.","DOI":"10.1038\/ng.3448"},{"key":"i1552-5783-60-4-1204-b49","doi-asserted-by":"crossref","unstructured":"Shen S, Jiang H, Bei Y, Xiao J, Li X. Long non-coding RNAs in cardiac remodeling. Cell Physiol Biochem. 2017; 41: 1830\u20131837.","DOI":"10.1159\/000471913"},{"key":"i1552-5783-60-4-1204-b50","doi-asserted-by":"crossref","unstructured":"Yang G, Yang L, Wang W, Wang J, Wang J, Xu Z. Discovery and validation of extracellular\/circulating microRNAs during idiopathic pulmonary fibrosis disease progression. Gene. 2015; 562: 138\u2013144.","DOI":"10.1016\/j.gene.2015.02.065"},{"key":"i1552-5783-60-4-1204-b51","doi-asserted-by":"crossref","unstructured":"Olivares AM, Jelcick AS, Reinecke J, et al. Multimodal regulation orchestrates normal and complex disease states in the retina. Sci Rep. 2017; 7: 690.","DOI":"10.1038\/s41598-017-00788-3"},{"key":"i1552-5783-60-4-1204-b52","doi-asserted-by":"crossref","unstructured":"Jun S, Datta S, Wang L, Pegany R, Cano M, Handa JT. The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE [published online ahead of print October 5, 2018]. Exp Eye Res. doi:10.1016\/j.exer.2018.09.023","DOI":"10.1016\/j.exer.2018.09.023"},{"key":"i1552-5783-60-4-1204-b53","doi-asserted-by":"crossref","unstructured":"Miyagishima KJ, Wan Q, Corneo B, et al. In pursuit of authenticity: induced pluripotent stem cell-derived retinal pigment epithelium for clinical applications. Stem Cells Transl Med. 2016; 5: 1562\u20131574.","DOI":"10.5966\/sctm.2016-0037"},{"key":"i1552-5783-60-4-1204-b54","doi-asserted-by":"crossref","unstructured":"Saini JS, Corneo B, Miller JD, et al. Nicotinamide ameliorates disease phenotypes in a human iPSC model of age-related macular degeneration. Cell Stem Cell. 2017; 20: 635\u2013647.","DOI":"10.1016\/j.stem.2016.12.015"},{"key":"i1552-5783-60-4-1204-b55","doi-asserted-by":"crossref","unstructured":"Micklisch S, Lin Y, Jacob S, et al. Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator. J Neuroinflammation. 2017; 14: 4.","DOI":"10.1186\/s12974-016-0776-3"},{"key":"i1552-5783-60-4-1204-b56","doi-asserted-by":"crossref","unstructured":"Rossberger S, Ach T, Best G, Cremer C, Heintzmann R, Dithmar S. High-resolution imaging of autofluorescent particles within drusen using structured illumination microscopy. Br J Ophthalmol. 2013; 97: 518\u2013523.","DOI":"10.1136\/bjophthalmol-2012-302350"},{"key":"i1552-5783-60-4-1204-b57","doi-asserted-by":"crossref","unstructured":"Trieschmann M, van Kuijk FJGM, Alexander R, et al. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye Lond Engl. 2008; 22: 132\u2013137.","DOI":"10.1038\/sj.eye.6702780"},{"key":"i1552-5783-60-4-1204-b58","doi-asserted-by":"crossref","unstructured":"Li M, Dolz-Marco R, Messinger JD, et al. Clinicopathologic correlation of anti-vascular endothelial growth factor-treated type 3 neovascularization in age-related macular degeneration. Ophthalmology. 2018; 125: 276\u2013287.","DOI":"10.1016\/j.ophtha.2017.08.019"},{"key":"i1552-5783-60-4-1204-b59","doi-asserted-by":"crossref","unstructured":"Litts KM, Messinger JD, Freund KB, Zhang Y, Curcio CA. Inner segment remodeling and mitochondrial translocation in cone photoreceptors in age-related macular degeneration with outer retinal tubulation. Invest Ophthalmol Vis Sci. 2015; 56: 2243\u20132253.","DOI":"10.1167\/iovs.14-15838"},{"key":"i1552-5783-60-4-1204-b60","doi-asserted-by":"crossref","unstructured":"Litts KM, Ach T, Hammack KM, et al. Quantitative analysis of outer retinal tubulation in age-related macular degeneration from spectral-domain optical coherence tomography and histology. Invest Ophthalmol Vis Sci. 2016; 57: 2647\u20132656.","DOI":"10.1167\/iovs.16-19262"},{"key":"i1552-5783-60-4-1204-b61","doi-asserted-by":"crossref","unstructured":"Finger RP, Chong E, McGuinness MB, et al. Reticular pseudodrusen and their association with age-related macular degeneration: The Melbourne Collaborative Cohort Study. Ophthalmology. 2016; 123: 599\u2013608.","DOI":"10.1016\/j.ophtha.2015.10.029"},{"key":"i1552-5783-60-4-1204-b62","doi-asserted-by":"crossref","unstructured":"Sivaprasad S, Bird A, Nitiahpapand R, et al. Perspectives on reticular pseudodrusen in age-related macular degeneration. Surv Ophthalmol. 2016; 61: 521\u2013537.","DOI":"10.1016\/j.survophthal.2016.02.005"},{"key":"i1552-5783-60-4-1204-b63","doi-asserted-by":"crossref","unstructured":"Domalpally A, Clemons TE, Danis RP, et al.; Writing Committee for the OPERA Study. Peripheral retinal changes associated with age-related macular degeneration in the Age-Related Eye Disease Study 2: Report Number 12. Ophthalmology. 2017; 124: 479\u2013487.","DOI":"10.1016\/j.ophtha.2016.12.004"},{"key":"i1552-5783-60-4-1204-b64","doi-asserted-by":"crossref","unstructured":"Kaszubski PA, Ben Ami T, Saade C, et al. Changes in reticular pseudodrusen area in eyes that progressed from early to late age-related macular degeneration. Int Ophthalmol. 2018; 38: 503\u2013511.","DOI":"10.1007\/s10792-017-0485-7"},{"key":"i1552-5783-60-4-1204-b65","doi-asserted-by":"crossref","unstructured":"Zanzottera EC, Messinger JD, Ach T, Smith RT, Curcio CA. Subducted and melanotic cells in advanced age-related macular degeneration are derived from retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2015; 56: 3269\u20133278.","DOI":"10.1167\/iovs.15-16432"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2729834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:02Z","timestamp":1791927062000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24254","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,29]]}}}